In this study, the results of tumor spheroid culture and colony formation in vitro showed that small-molecule inhibitors of the LPL/FABP4/CPT1 axis, including Orlistat, BMS309403 and Etomoxir, could inhibit the activity of LCSCs. Here, CPT1A is linked to neoplasm.